Explore our weight loss program, which includes GLP-1 medications, to learn how these treatments can work together for better results
Your body makes alpha-lipoic acid on its own
The U.S., by and large, doesn't set prices, so drug companies have more freedom to see what prices the market here will bear
The test reveals predispositions in GLP-1 metabolic pathways, providing context for your provider's discussion about whether GLP-1 therapy addresses your individual metabolic needs
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities
Muscle Regeneration and Repair GHK-Cu stimulates muscle fiber regeneration and tissue remodeling, making it a candidate for treating muscular dystrophies, age-related muscle loss, and recovery from musculoskeletal injuries